Keynote Financial Services LLC Takes $81,000 Position in Celularity Inc. (NASDAQ:CELU)

Keynote Financial Services LLC purchased a new stake in shares of Celularity Inc. (NASDAQ:CELU) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 15,566 shares of the company’s stock, valued at approximately $81,000.

Celularity Stock Performance

Shares of Celularity stock traded down $0.12 during trading on Friday, hitting $3.03. 9,496 shares of the stock traded hands, compared to its average volume of 15,535. Celularity Inc. has a 52-week low of $1.59 and a 52-week high of $7.97. The stock’s fifty day simple moving average is $3.08 and its 200 day simple moving average is $3.75.

Celularity Profile

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.